BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18612208)

  • 1. Estimating disease risk associated with mutated genes in family-based designs.
    Choi YH; Kopciuk KA; Briollais L
    Hum Hered; 2008; 66(4):238-51. PubMed ID: 18612208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal designs for estimating penetrance of rare mutations of a disease-susceptibility gene.
    Gong G; Whittemore AS
    Genet Epidemiol; 2003 Apr; 24(3):173-80. PubMed ID: 12652521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating penetrance from family data using a retrospective likelihood when ascertainment depends on genotype and age of onset.
    Carayol J; Bonaïti-Pellié C
    Genet Epidemiol; 2004 Sep; 27(2):109-17. PubMed ID: 15305327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating cancer risk in HNPCC by the GRL method.
    Alarcon F; Lasset C; Carayol J; Bonadona V; Perdry H; Desseigne F; Wang Q; Bonaïti-Pellié C
    Eur J Hum Genet; 2007 Aug; 15(8):831-6. PubMed ID: 17473834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating successive cancer risks in Lynch Syndrome families using a progressive three-state model.
    Choi YH; Briollais L; Green J; Parfrey P; Kopciuk K
    Stat Med; 2014 Feb; 33(4):618-38. PubMed ID: 23946183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correcting for ascertainment bias of relative-risk estimates obtained using affected-sib-pair linkage data.
    Cordell HJ; Olson JM
    Genet Epidemiol; 2000 Apr; 18(4):307-21. PubMed ID: 10797591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing studies to estimate the penetrance of an identified autosomal dominant mutation: cohort, case-control, and genotyped-proband designs.
    Gail MH; Pee D; Benichou J; Carroll R
    Genet Epidemiol; 1999; 16(1):15-39. PubMed ID: 9915565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARCAD: a method for estimating age-dependent disease risk associated with mutation carrier status from family data.
    Le Bihan C; Moutou C; Brugières L; Feunteun J; Bonaïti-Pellié C
    Genet Epidemiol; 1995; 12(1):13-25. PubMed ID: 7713397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robustness of inference on measured covariates to misspecification of genetic random effects in family studies.
    Pfeiffer RM; Hildesheim A; Gail MH; Pee D; Chen CJ; Goldstein AM; Diehl SR
    Genet Epidemiol; 2003 Jan; 24(1):14-23. PubMed ID: 12508252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.
    Barrow E; Alduaij W; Robinson L; Shenton A; Clancy T; Lalloo F; Hill J; Evans DG
    Clin Genet; 2008 Sep; 74(3):233-42. PubMed ID: 18554281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nonparametric method for penetrance function estimation.
    Alarcon F; Bonaïti-Pellié C; Harari-Kermadec H
    Genet Epidemiol; 2009 Jan; 33(1):38-44. PubMed ID: 18618769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting gene-environment independence in family-based case-control studies: increased power for detecting associations, interactions and joint effects.
    Chatterjee N; Kalaylioglu Z; Carroll RJ
    Genet Epidemiol; 2005 Feb; 28(2):138-56. PubMed ID: 15593088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-LRT: a likelihood approach to estimate genetic risks and test association with X-linked markers using a case-parents design.
    Zhang L; Martin ER; Chung RH; Li YJ; Morris RW
    Genet Epidemiol; 2008 May; 32(4):370-80. PubMed ID: 18278816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascertainment bias in the estimation of sibling genetic risk parameters.
    Olson JM; Cordell HJ
    Genet Epidemiol; 2000 Mar; 18(3):217-35. PubMed ID: 10723107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation.
    Lavie O; Gruber SB; Lejbkowicz F; Dishon S; Rennert G
    Am J Obstet Gynecol; 2008 Aug; 199(2):148.e1-3. PubMed ID: 18674656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A likelihood ratio approach to family-based association studies with covariates.
    Baksh MF; Balding DJ; Vyse TJ; Whittaker JC
    Ann Hum Genet; 2006 Jan; 70(Pt 1):131-9. PubMed ID: 16441262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling hazard functions in families.
    Siegmund K; McKnight B
    Genet Epidemiol; 1998; 15(2):147-71. PubMed ID: 9554553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report on de-novo mutation in the MSH2 gene as a rare event in hereditary nonpolyposis colorectal cancer.
    Morak M; Laner A; Scholz M; Madorf T; Holinski-Feder E
    Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1101-5. PubMed ID: 19047842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of population heterogeneity on risk estimation in genetic counseling.
    Liu W; Icitovic N; Shaffer ML; Chase GA
    BMC Med Genet; 2004 Jun; 5():18. PubMed ID: 15228628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.